chr1-43453627-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_001190880.3(HYI):c.167G>A(p.Gly56Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00181 in 1,496,150 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0013 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0019 ( 3 hom. )
Consequence
HYI
NM_001190880.3 missense
NM_001190880.3 missense
Scores
2
6
11
Clinical Significance
Conservation
PhyloP100: 4.78
Genes affected
HYI (HGNC:26948): (hydroxypyruvate isomerase (putative)) This gene encodes a putative hydroxypyruvate isomerase, which likely catalyzes the conversion of hydroxypyruvate to 2-hydroxy-3-oxopropanoate, and may be involved in carbohydrate transport and metabolism. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
SZT2 (HGNC:29040): (SZT2 subunit of KICSTOR complex) The protein encoded by this gene is expressed in the brain, predominantly in the parietal and frontal cortex as well as in dorsal root ganglia. It is localized to the peroxisome, and is implicated in resistance to oxidative stress. It likely functions by increasing superoxide dismutase (SOD) activity, but itself has no direct SOD activity. Studies in mice show that this gene confers low seizure threshold, and may also enhance epileptogenesis. [provided by RefSeq, Jun 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.22030288).
BP6
Variant 1-43453627-C-T is Benign according to our data. Variant chr1-43453627-C-T is described in ClinVar as [Benign]. Clinvar id is 1686343.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HYI | NM_001190880.3 | c.167G>A | p.Gly56Glu | missense_variant | 1/8 | ENST00000372430.9 | |
SZT2 | NM_001365999.1 | c.*3147C>T | 3_prime_UTR_variant | 72/72 | ENST00000634258.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HYI | ENST00000372430.9 | c.167G>A | p.Gly56Glu | missense_variant | 1/8 | 1 | NM_001190880.3 | P1 | |
SZT2 | ENST00000634258.3 | c.*3147C>T | 3_prime_UTR_variant | 72/72 | 5 | NM_001365999.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00130 AC: 198AN: 152136Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
198
AN:
152136
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00105 AC: 92AN: 87656Hom.: 0 AF XY: 0.000965 AC XY: 48AN XY: 49764
GnomAD3 exomes
AF:
AC:
92
AN:
87656
Hom.:
AF XY:
AC XY:
48
AN XY:
49764
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00187 AC: 2509AN: 1343908Hom.: 3 Cov.: 40 AF XY: 0.00178 AC XY: 1182AN XY: 662516
GnomAD4 exome
AF:
AC:
2509
AN:
1343908
Hom.:
Cov.:
40
AF XY:
AC XY:
1182
AN XY:
662516
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00129 AC: 197AN: 152242Hom.: 1 Cov.: 33 AF XY: 0.00128 AC XY: 95AN XY: 74434
GnomAD4 genome
AF:
AC:
197
AN:
152242
Hom.:
Cov.:
33
AF XY:
AC XY:
95
AN XY:
74434
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
16
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.;M;.
MutationTaster
Benign
D;N;N;N
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;.;.;D;D
REVEL
Benign
Sift
Uncertain
D;.;.;D;D
Sift4G
Uncertain
D;D;D;T;D
Polyphen
B;.;.;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at